Novel ITP Drug Helps Patients Ditch Daily Meds

(MedPage Today) — ORLANDO — Adding four monthly infusions of novel ianalumab helped adults with primary immune thrombocytopenia (ITP) achieve durable disease control in the second-line setting while stopping daily treatment with an oral platelet…